Cormorant Asset Management, LP Sarepta Therapeutics, Inc. Transaction History

Cormorant Asset Management, LP

$1.27 Billion
Q4 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$113.33 - $163.85 $14.2 Million - $20.5 Million	125,000 New	125,000 $19.8 Million
Q2 2023 Aug 14, 2023	BUY	$106.4 - $157.19 $2.13 Million - $3.14 Million	20,000 Added 18.18%	130,000 $14.9 Million
Q1 2023 May 15, 2023	SELL	$117.53 - $155.99 $10.6 Million - $14 Million	-90,000 Reduced 45.0%	110,000 $15.2 Million
Q3 2022 Nov 14, 2022	BUY	$75.71 - $119.24 $15.1 Million - $23.8 Million	200,000 New	200,000 $22.1 Million
Q2 2021 Aug 16, 2021	SELL	$69.38 - $86.75 $4.86 Million - $6.07 Million	-70,000 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$125.56 - $178.74 $1.88 Million - $2.68 Million	-15,000 Reduced 17.65%	70,000 $11.9 Million
Q3 2020 Nov 16, 2020	SELL	$127.12 - $172.34 $3.18 Million - $4.31 Million	-25,000 Reduced 22.73%	85,000 $11.9 Million
Q2 2020 Aug 14, 2020	SELL	$93.0 - $171.7 $3.72 Million - $6.87 Million	-40,000 Reduced 26.67%	110,000 $17.6 Million
Q1 2020 May 15, 2020	SELL	$82.38 - $131.64 $8.24 Million - $13.2 Million	-100,000 Reduced 40.0%	150,000 $14.7 Million
Q4 2019 Feb 14, 2020	BUY	$76.53 - $135.58 $2.17 Million - $3.84 Million	28,300 Added 12.76%	250,000 $32.3 Million
Q3 2019 Nov 14, 2019	SELL	$72.81 - $156.91 $240,273 - $517,803	-3,300 Reduced 1.47%	221,700 $16.7 Million
Q2 2019 Aug 14, 2019	SELL	$112.21 - $151.95 $8.42 Million - $11.4 Million	-75,000 Reduced 25.0%	225,000 $34.2 Million
Q1 2019 May 15, 2019	BUY	$106.67 - $151.68 $22.4 Million - $31.9 Million	210,000 Added 233.33%	300,000 $35.8 Million
Q4 2018 Feb 14, 2019	BUY	$97.32 - $148.76 $8.76 Million - $13.4 Million	90,000 New	90,000 $9.82 Million

Others Institutions Holding SRPT

# of Institutions

535

Shares Held

87.4M

Call Options Held

1.55M

Put Options Held

1.35M

Black Rock Inc. New York, NY

10.3M
Shares

$759 Million
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

9.09M
Shares

$668 Million
0.02% of portfolio
Capital International Investors Los Angeles, CA

8.7M
Shares

$640 Million
0.21% of portfolio
Janus Henderson Group PLC London, X0

4.33M
Shares

$318 Million
0.28% of portfolio
State Street Corp Boston, MA

4.07M
Shares

$299 Million
0.02% of portfolio

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $6.44B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Cormorant Asset Management, LP with notifications on news.

Account